Correlation Between Immunovant and 89bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Immunovant and 89bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunovant and 89bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunovant and 89bio Inc, you can compare the effects of market volatilities on Immunovant and 89bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunovant with a short position of 89bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunovant and 89bio.

Diversification Opportunities for Immunovant and 89bio

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Immunovant and 89bio is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Immunovant and 89bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 89bio Inc and Immunovant is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunovant are associated (or correlated) with 89bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 89bio Inc has no effect on the direction of Immunovant i.e., Immunovant and 89bio go up and down completely randomly.

Pair Corralation between Immunovant and 89bio

Given the investment horizon of 90 days Immunovant is expected to generate 1.1 times less return on investment than 89bio. But when comparing it to its historical volatility, Immunovant is 1.33 times less risky than 89bio. It trades about 0.15 of its potential returns per unit of risk. 89bio Inc is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  740.00  in 89bio Inc on July 30, 2024 and sell it today you would earn a total of  47.00  from holding 89bio Inc or generate 6.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Immunovant  vs.  89bio Inc

 Performance 
       Timeline  
Immunovant 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Immunovant are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Immunovant may actually be approaching a critical reversion point that can send shares even higher in November 2024.
89bio Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 89bio Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Immunovant and 89bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Immunovant and 89bio

The main advantage of trading using opposite Immunovant and 89bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunovant position performs unexpectedly, 89bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 89bio will offset losses from the drop in 89bio's long position.
The idea behind Immunovant and 89bio Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
CEOs Directory
Screen CEOs from public companies around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance